Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

Authors: Fehrenbacher, Louis | Breast Cancer Research And Treatment | March 1, 2022 | PubMed abstract

Explore all publications

Back To Top